Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Maxlinear Inc and Exar Corp (NYSE:EXAR)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
MaxLinear, Inc 0 10,431,634 0 10,431,634 10,431,634 20%
Eagle Acquisition Corporation 0 10,431,634 0 10,431,634 10,431,634 20%

Page 1 of 10 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

 

 

EXAR
CORPORATION

(Name of Issuer)

Common Stock, $0.0001 Par Value Per Share

(Title of Class of Securities)    

300645108

(CUSIP Number
of Class of Securities)

Kishore Seendripu, Ph. D.

President and Chief Executive Officer

MaxLinear, Inc.

5966 La
Place Court, Suite 100

Carlsbad, CA 92008

(760) 692-0711

With a
copy to:

Robert F. Kornegay

Wilson Sonsini Goodrich and Rosati P.C.

12235 El Camino Real, Suite 200

San Diego, CA 92130

(858) 350-2300

(Name,
Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 28, 2017

(Date of Event Which Requires Filing of this Statement)

 

 

If the filing
person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box:  ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for
other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page
shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (the Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!

Page 2 of 10 – SEC Filing


SCHEDULE 13D

CUSIP No. 300645108
  1 

Names of
Reporting Persons

MaxLinear, Inc.

  2

Check the Appropriate Box if a Member
of a Group (See Instructions)

(a)  ☐        (b)  ☐

  3

SEC Use Only

  4

Source of Funds (See Instructions)

    OO (See Item 3)

  5

Check if Disclosure of Legal
Proceeding Is Required Pursuant to Items 2(d) or 2(e)    ☐

  6

Citizenship or Place of
Organization

    Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7 

Sole Voting Power

    0

  8

Shared Voting Power

    10,431,634 (See Item 5)

  9

Sole Dispositive Power

    0

10

Shared Dispositive Power

    10,431,634 (See Item 5)

11

Aggregate Amount Beneficially Owned by Each Reporting Person

    10,431,634 (See Item 5)

12

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (See Instructions)    ☐

13

Percent of Class Represented by Amount
in Row (11)

    20% (See Item 5) (based on 51,192,445 shares of
Common Stock outstanding as of March 27, 2017)

14

Type of Reporting Person (See
Instructions)

    OO

2

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!

Page 3 of 10 – SEC Filing


SCHEDULE 13D

CUSIP No. 300645108
  1 

Names of
Reporting Persons

Eagle Acquisition Corporation

  2

Check the Appropriate Box if a Member
of a Group (See Instructions)

(a)  ☐        (b)  ☐

  3

SEC Use Only

  4

Source of Funds (See Instructions)

    OO (See Item 3)

  5

Check if Disclosure of Legal
Proceeding Is Required Pursuant to Items 2(d) or 2(e)    ☐

  6

Citizenship or Place of
Organization

    Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7 

Sole Voting Power

    0

  8

Shared Voting Power

    10,431,634 (See Item 5)

  9

Sole Dispositive Power

    0

10

Shared Dispositive Power

    10,431,634 (See Item 5)

11

Aggregate Amount Beneficially Owned by Each Reporting Person

    10,431,634 (See Item 5)

12

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (See Instructions)    ☐

13

Percent of Class Represented by Amount
in Row (11)

    20% (See Item 5) (based on 51,192,445 shares of
Common Stock outstanding as of March 27, 2017)

14

Type of Reporting Person (See
Instructions)

    OO

3

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!

Page 4 of 10 – SEC Filing


Item 1. Security and Issuer

This statement on Schedule 13D (this Statement) is being filed on behalf of the Reporting Persons (as defined in Item 2(a)
below) with respect to the shares of Common Stock, par value $0.0001 per share (the Common Stock) of Exar Corporation, a Delaware corporation (Exar), whose principal executive offices are located at 48720 Kato
Road, Fremont, CA 94538.

Item 2. Identity and Background.

(a) This Statement is being filed jointly on behalf of MaxLinear, Inc., a Delaware Corporation (MaxLinear) and Eagle Acquisition
Corporation, a Delaware corporation and wholly owned subsidiary of MaxLinear (Purchaser).

Schedule I hereto,
with respect to MaxLinear and Schedule II hereto, with respect to Purchaser sets forth lists of all the directors/managers and executive officers or persons holding equivalent positions (the Scheduled Persons) of each such
Reporting Person.

The Reporting Persons have entered into a Joint Filing Agreement, dated March 31, 2017, a copy of which is attached
as Exhibit 99.1 hereto, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) of the Act.

(b) The address of the principal business and principal office of each of the Reporting Persons is c/o MaxLinear, Inc., 5966 La Place Court, Suite 100,
Carlsbad, CA 92008. Schedule I and Schedule II hereto set forth the principal business address of each Scheduled Person.

(c) MaxLinear
is a provider of radio frequency, or RF, and mixed-signal integrated circuits for cable and satellite broadband communications and the connected home, and wired and wireless infrastructure markets. Its high performance RF receiver products capture
and process digital and analog broadband signals to be decoded for various applications. The preceding description of MaxLinear and its business has been taken from MaxLinears Annual Report on Form 10-K
for the fiscal year ended December 31, 2016 and is qualified in its entirety by reference to such Form 10-K. Purchaser is a Delaware corporation incorporated on March 27, 2017 and a wholly owned
subsidiary of MaxLinear. Purchaser was formed solely for the purpose of completing the proposed Offer and Merger and has conducted no business activities other than those related to the structuring and negotiating of the Offer and the Merger.
Purchaser has minimal assets and liabilities other than the contractual rights and obligations related to the Acquisition Agreement. Schedule I and Schedule II hereto set forth the principal occupation or employment of each Scheduled
Person.

(d) During the last five years, none of the Reporting Persons nor any of the Scheduled Persons has been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors).

(e) During the last five years, none of the Reporting Persons nor any of the Scheduled
Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws.

(f) MaxLinear and
Purchaser are organized under the laws of the State of Delaware. Schedule I and Schedule II hereto set forth the citizenship of each Scheduled Person.

Item 3. Sources and Amount of Funds or Other Consideration

As described in response to Item 4, the shares of Common Stock to which this Statement relates have not been purchased by the Reporting Persons
as of the date of this filing, and thus no funds were used for this purpose.

It is anticipated that the funding for the transactions
contemplated by the Acquisition Agreement (as defined in Item 4 below) (the Transactions) will consist of a combination of cash from the combined balance sheets of MaxLinear and Exar and a term loan facility. JPMorgan Chase Bank,
N.A., Deutsche Bank AG New York Branch Deutsche Bank Securities Inc. and MaxLinear have entered into a debt commitment letter in connection with the Acquisition Agreement.

As a condition to MaxLinears and Purchasers willingness to enter into the Acquisition Agreement, MaxLinear and Purchaser entered
into Support Agreements (as defined in Item 4 below) with the Supporting Stockholders (as defined in Item 4 below). Pursuant to, and subject to the terms and conditions of, the Support Agreements, each Supporting Stockholder has agreed, among other

4

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!

Page 5 of 10 – SEC Filing


things, to tender, and not withdraw, the Subject Shares (as defined in Item 4 below) without the prior written consent of MaxLinear. None of the Reporting Persons or Exar paid additional
consideration to the Supporting Stockholders in connection with the execution and delivery of the Support Agreements.

Item 4. Purpose of
Transaction.

Acquisition Agreement and Tender Offer

On March 28, 2017, MaxLinear and Purchaser entered into an Acquisition Agreement with Exar, a copy of which has been filed as Exhibit 2.1
to the MaxLinears Current Report on Form 8-K filed on March 29, 2017, and is incorporated by reference in its entirety as Exhibit 99.2 (the Acquisition Agreement). Under the
Acquisition Agreement, among other things, Purchaser will commence a tender offer (the Offer) to purchase all of the Common Stock, at a price per share of $13.00, net to the holders thereof in cash, without interest (the
Offer Price). Upon successful completion of the Offer, and subject to the terms and conditions of the Acquisition Agreement, Purchaser will be merged with and into Exar (the Merger), and Exar will survive the
Merger as a direct wholly owned subsidiary of MaxLinear. The Merger will be governed by Section 251(h) of the General Corporation Law of the State of Delaware (the DGCL), with no stockholder vote required to consummate the Merger.
After consummation of the Acquisition Agreement, the certificate of incorporation, bylaws, directors and officers of the surviving corporation will be that of Purchaser.

Support Agreements

In connection
with the execution and delivery of the Acquisition Agreement, MaxLinear and Purchaser entered into, in each case dated as of March 28, 2015, a support agreement with each of (i) Behrooz Abdi, (ii) Rodfre Investments, Inc., (iii) Izak
Bencuya, (iv) Ryan A. Benton, (v) Pierre Guilbault, (vi) Brian Hilton, (vii) Hung Le, (viii) James Lougheed, (ix) Gary Meyers, (x) Simcoe Partners, L.P., Simcoe Management Company, LLC, SDR Partners, LLC, Simcoe
Capital Management, LLC, and Jeffrey Jacobowitz (together, the Simcoe Affiliates), (xi) Keith Tainsky and (xii) Daniel Wark (collectively, the Support Agreements) (the persons described in clauses
(i) through (xii), collectively, the Supporting Stockholders). Pursuant to and subject to the terms and conditions of the Support Agreements, the Supporting Stockholders agreed, subject to certain limited specified exceptions
as set forth therein, to tender, and not withdraw, all outstanding shares of Common Stock beneficially owned by them, or acquired by them after such date (collectively, the Subject Shares). In addition, pursuant to and subject to
the terms and conditions of the Support Agreements, the Supporting Stockholders have agreed, subject to certain exceptions as set forth therein, to refrain from transferring, selling or otherwise disposing of the Subject Shares and soliciting
alternative acquisition proposals to the Transactions. The Support Agreements will automatically terminate upon certain circumstances, including upon termination of the Acquisition Agreement.

Based upon information provided by the Supporting Stockholders in their respective Support Agreements, as of March 28, 2017, the Subject
Shares included: (i) 29,540 Shares of Common Stock beneficially owned by Behrooz Abdi, (ii) 7,591,605 Shares of Common Stock beneficially owned by Rodfre Investments, Inc., (iii) 45,000 Shares of Common Stock beneficially owned by Izak Bencuya, (iv)
18,205 Shares of Common Stock beneficially owned by Ryan A. Benton, (v) 14,500 Shares of Common Stock beneficially owned by Pierre Guilbault, (vi) 38,000 Shares of Common Stock beneficially owned by Brian Hilton, (vii) 2,818 Shares of Common Stock
beneficially owned by Hung Le, (viii) 25,805 Shares of Common Stock beneficially owned by James Lougheed, (ix) 63,625 Shares of Common Stock beneficially owned by Gary Meyers, (x) 2,577,901 Shares of Common Stock beneficially owned by the Simcoe
Affiliates, (xi) 0 Shares of Common Stock beneficially owned by Keith Tainsky and (xii) 24,635 Shares of Common Stock beneficially owned by Daniel Wark.

The Reporting Persons may be deemed to have acquired shared voting and disposition power with respect to the Subject Shares by reason of the
execution and delivery of the Support Agreements by MaxLinear and Purchaser.

The foregoing descriptions of the Acquisition Agreement and
the Support Agreements do not purport to be complete and are qualified in their entirety by reference to such agreements. The Acquisition Agreement and the Support Agreements are each attached hereto as Exhibits 99.2, 99.3, 99.4, 99.5, 99.6, 99.7,
99.8, 99.9, 99.10, 99.11, 99.12, 99.13 and 99.14 respectively, to this Statement and incorporated by referenced herein.

The primary
purpose of the transactions described above is for MaxLinear, through Purchaser, to acquire all of the outstanding shares of Common Stock. MaxLinear required that the Supporting Stockholders agree to enter into the Support Agreements as part of the
inducements for MaxLinear and Purchaser to enter into the Acquisition Agreement and to consummate the Transactions, including the Offer and the Merger. Upon consummation of the Transactions, Exar will become a wholly-owned subsidiary of MaxLinear,
the Common Stock will cease to be freely traded or listed and will be de-registered under the Act.

Except as set forth in this Statement or as contemplated by the Acquisition Agreement and the Support Agreements, none of the Reporting
Persons nor, to the knowledge of the Reporting Persons, any of the Scheduled Persons has any present plans or proposals which relate to or which would result in any of the transactions described in subparagraphs (a) through (j) of

5

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!

Page 6 of 10 – SEC Filing


Item 4 of Schedule 13D.

Item 5. Interest in Securities of the Issuer.

(a) The Supporting Stockholders collectively own 10,431,634 shares of Common Stock. The Reporting Persons, for the purpose of Rule 13d-3 under the Act, therefore may, by reason of the execution and delivery of the Support Agreements, be deemed to share beneficial ownership over 10,431,634 shares of Common Stock, which would represent 20% of the
Common Stock, issued and outstanding as of March 27, 2017, as disclosed in the Acquisition Agreement. Other than for the purposes of Rule 13d-3 under the Act, the Reporting Persons expressly disclaim
beneficial ownership of such shares, and nothing herein shall be deemed to be an admission by the Reporting Persons as to the beneficial ownership of such shares. To the Reporting Persons knowledge, no shares of Common Stock are beneficially
owned by any Scheduled Person.

(b) The Reporting Persons, by reason of the execution and delivery of the Support Agreements, may be deemed to have
shared dispositive power with the Supporting Stockholders with respect to 10,431,634 shares of Common Stock, representing approximately 20% of the Common Stock, issued and outstanding as of March 27, 2017, as disclosed in the Acquisition
Agreement. Neither the filing of this Statement nor any of its contents shall be deemed to constitute an admission that any Reporting Person or any of its affiliates is the beneficial owner of any shares of Common Stock for purposes of Section 13(d)
of the Act or for any other purpose. The Reporting Persons (i) are not entitled to any rights as a stockholder of Exar as to the Subject Shares, except as otherwise expressly provided in the Support Agreements, and (ii) have no power to
vote, direct the voting of, dispose of, or direct the disposal of, any shares of Common Stock other than the power provided pursuant to the Support Agreements.

(c) Except as described in this Statement (including the schedules to this Statement), during the last sixty (60) days there were no transactions in
the Common Stock effected by the Reporting Persons or the Scheduled Persons.

(d) Except as set forth in this Item 5 and for persons referred to in
Items 2 and 4 above, no person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock that may be deemed to be beneficially owned by the Reporting Persons.

(e) Not applicable.

Item 6. Contracts,
Arrangements, Understandings, or Relationships with Respect to Securities of the Issuer.

Pursuant to Rule 13d-1(k) promulgated under the Act, the Reporting Persons have entered into a Joint Filing Agreement, attached hereto as Exhibit 99.1 and incorporated by reference herein, with respect to the joint filing of this
Statement and any amendments thereto. The information set forth, or incorporated by reference, in Item 3 through 5 of this Statement is hereby incorporated by reference into this Item 6. Except as described herein, there are no contracts,
arrangements, undertakings or relationships (legal or otherwise) among the persons named in Item 2 above or between such persons and any other person with respect to any securities of the Company.

Item 7. Material to be Filed as Exhibits.

Exhibit 99.1 Joint Filing Agreement, dated March 31, 2017, by and between the Reporting Persons.
Exhibit 99.2 Acquisition Agreement among MaxLinear, Inc., Eagle Acquisition Corporation, and Exar Corporation, dated as of March 28, 2017 (incorporated by reference to Exhibit 2.1 to MaxLinears Current Report on Form 8-K filed on March 29, 2017).
Exhibit 99.3 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation, and Behrooz Abdi.
Exhibit 99.4 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and Rodfre Investments, Inc.
Exhibit 99.5 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and Izak Bencuya.
Exhibit 99.6 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and Ryan A. Benton.

6

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!

Page 7 of 10 – SEC Filing


Exhibit 99.7 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and Pierre Guilbault.
Exhibit 99.8 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and Brian Hilton.
Exhibit 99.9 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and Hung Le.
Exhibit 99.10 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and James Lougheed.
Exhibit 99.11 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and Gary Meyers.
Exhibit 99.12 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation, Simcoe Partners, L.P., Simcoe Management Company, LLC, SDR Partners, LLC, Simcoe Capital Management, LLC, and Jeffrey
Jacobowitz.
Exhibit 99.13 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and Keith Tainsky.
Exhibit 99.14 Support Agreement, dated as of March 28, 2017, by and among MaxLinear, Inc., Eagle Acquisition Corporation and Daniel Wark.

7

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!

Page 8 of 10 – SEC Filing


SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement
is true, complete and correct.

Dated: April 4, 2017 MAXLINEAR, INC.
By:

/s/ Kishore Seendripu

Name: Kishore Seendripu
Title: President and Chief Executive Officer
Dated: April 4, 2017 EAGLE ACQUISITION CORPORATION
By:

/s/ Kishore Seendripu

Name: Kishore Seendripu
Title: President and Chief Executive Officer

8

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!

Page 9 of 10 – SEC Filing


SCHEDULE I

MaxLinear, Inc.

Name and Position of Officer/Manager Principal Business Address

Principal Occupation or

Employment

Citizenship

Kishore Seendripu

Chairman of the Board, President and

Chief Executive Officer

5966 La Place Court, Suite 100

Carlsbad, CA 92008

President and Chief Executive Officer

of MaxLinear, Inc.

USA

Thomas E. Pardun

Lead Director

5966 La Place Court, Suite 100

Carlsbad, CA 92008

USA

Steven C. Craddock

Director

5966 La Place Court, Suite 100

Carlsbad, CA 92008

USA

Curtis Ling

Director

5966 La Place Court, Suite 100

Carlsbad, CA 92008

Chief Technical Officer of MaxLinear, Inc. USA

Albert J. Moyer

Director

5966 La Place Court, Suite 100

Carlsbad, CA 92008

USA

Donald E. Schrock

Director

5966 La Place Court, Suite 100

Carlsbad, CA 92008

USA

Ted Tewksbury

Director

5966 La Place Court, Suite 100

Carlsbad, CA 92008

USA

Kathi Guiney

Vice President of Human Resources

5966 La Place Court, Suite 100

Carlsbad, CA 92008

Vice President of Human Resources of MaxLinear, Inc. USA

Adam C. Spice

Chief Financial Officer

5966 La Place Court, Suite 100

Carlsbad, CA 92008

Chief Financial Officer

of MaxLinear, Inc.

Canada

Michael J. LaChance

Vice President of Operations

5966 La Place Court, Suite 100

Carlsbad, CA 92008

Vice President of Operations

of MaxLinear, Inc.

USA

Madhukar Reddy

Vice President of IC and RF Systems Engineering

5966 La Place Court, Suite 100

Carlsbad, CA 92008

Vice President of IC and RF Systems Engineering of MaxLinear, Inc. USA

William Torgerson

Vice President & General Manager of Broadband Group

5966 La Place Court, Suite 100

Carlsbad, CA 92008

Vice President & General Manager of Broadband Group of MaxLinear, Inc. USA

Brendan Walsh

Vice President of Product Line Marketing, Infrastructure Group

5966 La Place Court, Suite 100

Carlsbad, CA 92008

Vice President of Product Line Marketing, Infrastructure Group of MaxLinear, Inc. USA

Dana McCarty

Vice President of Global Sales

5966 La Place Court, Suite 100

Carlsbad, CA 92008

Vice President of Global Sales

of MaxLinear, Inc.

USA

9

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!

Page 10 of 10 – SEC Filing


SCHEDULE II

Eagle Acquisition Corporation

Name and Position of Officer/Director

Principal Business Address

Principal Occupation or
Employment

Citizenship

Kishore Seendripu

President and Chief Executive Officer

5966 La Place Court, Suite 100

Carlsbad, CA 92008

President and Chief Executive Officer of MaxLinear USA

Adam Spice

Secretary and Treasurer

5966 La Place Court, Suite 100

Carlsbad, CA 92008

Chief Financial Officer of MaxLinear Canada

10

Follow Exar Corp (NYSE:EXAR)
Trade (NYSE:EXAR) Now!